Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release Prestigious Medical and Public Health Journal THE LANCET Regional Health Publishes Pivotal Phase 3 Clinical Study on Miqnaf® (Nafithromycin) A Landmark for India s Antibiotic Innovation .